Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia-Reference-Cited by-同舟云学术

Impact of hydroxyurea dose and adherence on hematologic outcomes for children with sickle cell anemia

Published:2022-04-04 Issue:6 Volume:69 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatric Blood & Cancer

Author:

Creary Susan E.¹²^ORCID,Beeman Chase¹,Stanek Joseph²^ORCID,King Kathryn³,McGann Patrick T.⁴^ORCID,O'Brien Sarah H.¹²^ORCID,Liem Robert I.³^ORCID,Holl Jane⁵,Badawy Sherif M.³⁶^ORCID

Affiliation:

1. Center for Child Health Equity and Outcomes Research Institute Nationwide Children's Hospital Columbus Ohio USA

2. Division of Pediatric Hematology/Oncology/BMT Nationwide Children's Hospital and The Ohio State University Columbus Ohio USA

3. Division of Hematology, Oncology and Stem Cell Transplantation Ann & Robert H. Lurie Children's Hospital of Chicago Chicago Illinois USA

4. Department of Pediatrics The Warren Alpert Medical School of Brown University, Hasbro Children's Hospital and Rhode Island Hospital Providence Rhode Island USA

5. Department of Neurology and Center for Healthcare Delivery Science and Innovation University of Chicago Chicago Illinois USA

6. Department of Pediatrics Northwestern University Feinberg School of Medicine Chicago Illinois USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29607

Reference42 articles.

1. A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia

2. The effect of hydroxcarbamide therapy on survival of children with sickle cell disease

3. Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of self-management education on clinical outcomes of adults with rheumatic heart disease: A quasi-experimental study;Current Problems in Cardiology;2024-11

2. Study protocol for ADHERE (Applying Directly observed therapy to HydroxyurEa to Realize Effectiveness): Using small business partnerships to deliver a scalable and novel hydroxyurea adherence solution to youth with sickle cell disease;PLOS ONE;2024-06-25

3. Impact of hydroxyurea on clinical and biological parameters of sickle cell anemia in children in Abidjan;Mediterranean Journal of Hematology and Infectious Diseases;2024-02-29

4. Barriers to medication adherence in sickle cell disease: A comprehensive theory‐based evaluation using the COM‐B model;Pediatric Blood & Cancer;2023-05-27

5. Recent progress in the treatment of sickle cell disease: an up-to-date review;Beni-Suef University Journal of Basic and Applied Sciences;2023-04-13